PLOS ONE: Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma
![Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience | Cancer Communications | Full Text Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience | Cancer Communications | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40880-019-0395-3/MediaObjects/40880_2019_395_Fig1_HTML.png)
Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience | Cancer Communications | Full Text
![Mayo Clinic Rochester Publishes Updated Multiple Myeloma Survival Rates! - Multiple Myeloma - Survival Rate Statistics by Hospital Mayo Clinic Rochester Publishes Updated Multiple Myeloma Survival Rates! - Multiple Myeloma - Survival Rate Statistics by Hospital](http://myelomasurvival.com/uploads/3/4/4/8/34484049/mayoos-and-ss-tables_orig.png)
Mayo Clinic Rochester Publishes Updated Multiple Myeloma Survival Rates! - Multiple Myeloma - Survival Rate Statistics by Hospital
![Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/480689df-d7d2-4224-9823-835cc1312b92/gr1.jpg)
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet
![Daratumumab, Lenalinomide, and Dexamethasone for Myeloma | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og ... Daratumumab, Lenalinomide, and Dexamethasone for Myeloma | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og ...](https://resident360files.nejm.org/image/authenticated/s--ujoispcN--/NEJMoa1817249_f1_iejec3.jpg)
Daratumumab, Lenalinomide, and Dexamethasone for Myeloma | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og ...
![Frontiers | Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | Oncology Frontiers | Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | Oncology](https://www.frontiersin.org/files/Articles/459583/fonc-09-00633-HTML/image_m/fonc-09-00633-g002.jpg)
Frontiers | Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | Oncology
![Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma - ScienceDirect Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2531137920301139-gr3.jpg)
Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma - ScienceDirect
![The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press](https://www.atlantis-press.com/assets/articles/CHI-1-4-220/CHI-1-4-220-g006.png)
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
![Impact of Novel Therapies on Multiple Myeloma Survival– Current and Future Outcomes - Clinical Lymphoma, Myeloma and Leukemia Impact of Novel Therapies on Multiple Myeloma Survival– Current and Future Outcomes - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2037463197/2051919195/fx1.jpg)
Impact of Novel Therapies on Multiple Myeloma Survival– Current and Future Outcomes - Clinical Lymphoma, Myeloma and Leukemia
![Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance](https://f6publishing.blob.core.windows.net/0e9eaf16-088a-4ffb-9ed9-4c6aa1a3e465/WJCC-7-4234-g002.png)
Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance
![Transformation of Multiple Myeloma from Fatal to Chronic Disease in Terms of Overall Survival Trends | CELG Message Board Posts Transformation of Multiple Myeloma from Fatal to Chronic Disease in Terms of Overall Survival Trends | CELG Message Board Posts](https://www.investorvillage.com/uploads/9279/images/MM_OS_Transforms.png)
Transformation of Multiple Myeloma from Fatal to Chronic Disease in Terms of Overall Survival Trends | CELG Message Board Posts
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
![Time-dependent endpoints as predictors of overall survival in multiple myeloma | BMC Cancer | Full Text Time-dependent endpoints as predictors of overall survival in multiple myeloma | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-13-122/MediaObjects/12885_2012_Article_3757_Fig2_HTML.jpg)
Time-dependent endpoints as predictors of overall survival in multiple myeloma | BMC Cancer | Full Text
![Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome | Blood Cancer Journal Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-018-0163-7/MediaObjects/41408_2018_163_Fig1_HTML.png)
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome | Blood Cancer Journal
![The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press](https://www.atlantis-press.com/assets/articles/CHI-1-4-220/CHI-1-4-220-g005.png)
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France
![Overall survival from diagnosis of multiple myeloma, according to world... | Download Scientific Diagram Overall survival from diagnosis of multiple myeloma, according to world... | Download Scientific Diagram](https://www.researchgate.net/profile/Guillermo-Ruiz-Argueelles/publication/330920624/figure/fig2/AS:960056833093661@1605906794561/Overall-survival-from-diagnosis-of-multiple-myeloma-according-to-world-region-and.png)
Overall survival from diagnosis of multiple myeloma, according to world... | Download Scientific Diagram
![Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. | Semantic Scholar Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cd5c45b45e2148738cf5049d64e808e18e247c9f/3-Figure1-1.png)